2603003257
  • Open Access
  • Article

Hydrocortisone Impairs the Activity of Antimicrobial Drugs against Clinical Isolates of Staphylococcus aureus

  • Jefferson Costa 1,   
  • Vanderson Silva 1,   
  • Aline de Oliveira Peres 1,   
  • Rafael Rezende 1,   
  • Sarah Ferreira Martins 1,   
  • Viviane Braga de Aguiar 1,   
  • Marcus Vinícius Dias-Souza 2,*

Received: 23 Dec 2025 | Revised: 27 Jan 2026 | Accepted: 09 Mar 2026 | Published: 26 Mar 2026

Abstract

The clinical use of antimicrobials has increased the chances of cure and life expectancy. However, indiscriminate use and/or incorrect prescription have aggravated the worrying scenario of bacterial resistance. In antimicrobial therapies, the combined use of corticosteroids aims to modulate the inflammatory process triggered by the infection and prevent adverse reactions from antimicrobials such as nephrotoxicity. Several combinations are available as topical formulations, and they are commonly prescribed in the same device for intravenous administration in hospitals. Notwithstanding eventual benefits, the safety of these combinations remains poorly investigated. The aim of the present study was to conduct in vitro tests to assess the interference of hydrocortisone on the antimicrobial activity of some drugs against clinical isolates of Staphylococcus aureus and to provide insights into the chemical nature of such interactions. Tests of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were performed with and without the addition of hydrocortisone (HYDRO). Chemoinformatics data on predicted NMR, GC-MS and FTIR spectra of the drugs to obtain chemical data that could support a more detailed analysis of potential interaction. HYDRO elevated MIC and MBC of oxacillin, and abrogated the activity of gentamicin and chloramphenicol, suggesting that these combinations may pose a risk to clinical treatments. More studies should be carried out in animal models to confirm these effects in vivo.

References 

  • 1.

    Tópor, A. Resistência a Antimicrobianos e Fatores de Virulência em Klebsiella sp. Isoladas da Laguna de Tramandaí. In Proceedings of the IX Simpósio Brasileiro de Microbiologia Aplicada, Porto Alegre, Brazil, 23–25 November 2016.

  • 2.

    World Health Organization. Global Strategy for Containment of Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2001.

  • 3.

    Grill, M.F.; Maganti, R.K. Neurotoxic effects associated with antibiotic use: Management considerations. Br. J. Clin. Pharmacol. 2011, 72, 381–393.

  • 4.

    Flaherty, K.R.; King, T.E.; Raghu, G.; Lynch, J.P.; Colby, T.V.; Travis, W.D.; Gross, B.H.; Kazerooni, E.A.; Toews, G.B. Idiopathic interstitial pneumonia: What is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004, 170, 904–910.

  • 5.

    Gimenes, M.; Salci, T.P.; Tognim, M.C.; Borsato, A.S.; Pelisson, M.; Svidzinski, T.I.E. Treating Staphylococcus aureus infections in an intensive care unit at a university hospital in Brazil. Int. J. Clin. Pharm. 2016, 38, 228–232.

  • 6.

    Gomes, A.; Rodrigues, A.; Monteiro, A.; Marçal, P.H.; Dias-Souza, M.V. Dexamethasone can decrease the post-antibiotic effect of different drugs against Staphylococcus aureus and Pseudomonas aeruginosa strains. J. Appl. Pharm. Sci. 2016, 3, 2–4.

  • 7.

    Rodrigues, A.; Gomes, A.; Marçal, P.H.; Dias-Souza, M.V. Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa. J. Adv. Res. 2017, 8, 55–61.

  • 8.

    Esposito, S.; Semino, M.; Picciolli, I.; Principi, N. Should corticosteroids be used in bacterial meningitis in children? Eur. J. Paediatr. Neurol. 2013, 17, 24–28.

  • 9.

    Coşkun, E.; Duman, E.; Acar, N.; Biçer, E. Electrochemical, spectroscopic and computational studies on complexation of oxacillin with Cu(II) and Co(II) ions: Synthesis and ligand hydrolysis. Int. J. Electrochem. Sci. 2017, 12, 9364–9377.

  • 10.

    Canpolat, F.; Erkoçoğlu, M.; Tezer, H.; Kandiş, H.; Atakan, N. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age: A randomized double-blind pilot trial. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 1989–1993.

  • 11.

    Hon, K.L.; Wang, S.S.; Lee, K.K.; Chan, K.H.; Leung, T.F. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: Friend or foe? J. Drugs Dermatol. 2012, 11, 861–864.

  • 12.

    Joosten, A.; Maertens, J.; Verhaegen, J.; Lagrou, K.; Van Wijngaerden, E. High incidence of bloodstream infection detected by surveillance blood cultures in hematology patients on corticosteroid therapy. Support. Care Cancer 2012, 20, 3013–3017.

  • 13.

    Bergeron, M.G.; Bergeron, Y.; Beauchamp, D. Influence of hydrocortisone succinate on intrarenal accumulation of gentamicin in endotoxemic rats. Antimicrob. Agents Chemother. 1987, 31, 1816–1821.

  • 14.

    Crowther, J.A.; Simpson, D. Medical treatment of chronic otitis media: Steroid or antibiotic with steroid ear-drops? Clin. Otolaryngol. Allied Sci. 1991, 16, 142–144.

  • 15.

    Dohar, J.E.; Roland, P.; Wall, M.G.; McLean, C.; Hannley, M.; Hovde, S. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: Results of a combined analysis. Curr. Med. Res. Opin. 2009, 25, 287–291.

  • 16.

    Magnussen, P.; Yakubu, A.; Bloch, P. The effect of antibiotic- and hydrocortisone-containing ointments in preventing secondary infections in guinea worm disease. Am. J. Trop. Med. Hyg. 1994, 51, 797–799.

  • 17.

    Gong, J.Q.; Lin, L.; Lin, T.; Hao, F.; Zeng, F.Q.; Bi, Z.G.; Yi, D.; Zhao, B.; Liu, Y.D.; Li, S.X.; et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: A double-blind multicentre randomized controlled trial. Br. J. Dermatol. 2006, 155, 680–687.

  • 18.

    Huang, G.; Lu, Y.; Lu, C.; Wang, M.; Liu, X.; Zhu, W. Prediction of drug indications based on chemical interactions and chemical similarities. Biomed Res. Int. 2015, 2015, 584546.

  • 19.

    Yang, M.; Luo, H.; Li, Y.; Wang, J.; Yao, Q.; Wu, Y. Overlap matrix completion for predicting drug-associated indications. PLoS Comput. Biol. 2019, 15, e1007541.

  • 20.

    Ramírez, D.; Caballero, J. Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target? Int. J. Mol. Sci. 2016, 17, 525.

Share this article:
How to Cite
Costa, J.; Silva, V.; de Oliveira Peres, A.; Rezende, R.; Ferreira Martins, S.; Braga de Aguiar, V.; Dias-Souza, M. V. Hydrocortisone Impairs the Activity of Antimicrobial Drugs against Clinical Isolates of Staphylococcus aureus. Journal of Inflammatory and Infectious Medicine 2026, 2 (1), 3. https://doi.org/10.53941/jiim.2026.100003.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.